PT  - JOURNAL ARTICLE
AU  - Sofonea, Mircea T.
AU  - Reyné, Bastien
AU  - Elie, Baptiste
AU  - Djidjou-Demasse, Ramsès
AU  - Selinger, Christian
AU  - Michalakis, Yannis
AU  - Alizon, Samuel
TI  - Epidemiological monitoring and control perspectives: application of a parsimonious modelling framework to the COVID-19 dynamics in France
AID  - 10.1101/2020.05.22.20110593
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.22.20110593
4099  - http://medrxiv.org/content/early/2020/05/24/2020.05.22.20110593.short
4100  - http://medrxiv.org/content/early/2020/05/24/2020.05.22.20110593.full
AB  - SARS-Cov-2 virus has spread over the world creating one of the fastest pandemics ever. The absence of immunity, asymptomatic transmission, and the relatively high level of virulence of the COVID-19 infection it causes led to a massive flow of patients in intensive care units (ICU). This unprecedented situation calls for rapid and accurate mathematical models to best inform public health policies. We develop an original parsimonious model that accounts for the effect of the age of infection on the natural history of the disease. Analysing the ongoing COVID-19 in France, we estimate the value of the key epidemiological parameters, such as the basic reproduction number , and the efficiency of the national control strategy. We then use our deterministic model to explore several scenarios posterior to lock-down lifting and compare the efficiency of non pharmaceutical interventions (NPI) described in the literature.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge support from the University of Montpellier, the CNRS and the IRDAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:As a modelling study, this step was not required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data here used are publicly available and their references indicated.